<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SpineJournal.gr &#124; Spine News &#187; Alex Lukianov</title>
	<atom:link href="http://www.spinejournal.gr/tag/alex-lukianov/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.spinejournal.gr</link>
	<description>Exclusively Spine Market News</description>
	<lastBuildDate>Wed, 08 Sep 2010 11:18:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>NuVasive Reports Second Quarter 2010 Financial Results</title>
		<link>http://www.spinejournal.gr/2010/08/nuvasive-reports-second-quarter-2010-financial-results/</link>
		<comments>http://www.spinejournal.gr/2010/08/nuvasive-reports-second-quarter-2010-financial-results/#comments</comments>
		<pubDate>Sun, 01 Aug 2010 16:01:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Alex Lukianov]]></category>
		<category><![CDATA[nuvasive]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=893</guid>
		<description><![CDATA[SAN DIEGO, CA, Jul 27, 2010 (MARKETWIRE via COMTEX) &#8212; NuVasive, Inc.
&#8211; Total revenue of $119.6 million, up 35.2% over second quarter 2009
&#8211; GAAP earnings of $6.7 million, or $0.17 per share; Non-GAAP earnings  of $17.0 million, or $0.42 per share
&#8211; Non-GAAP operating margin of 15.8%, up from 11.3% for first quarter
   [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/08/nuvasive-reports-second-quarter-2010-financial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive Announces Preliminary Unaudited Full Year 2009 Financial Results</title>
		<link>http://www.spinejournal.gr/2010/02/nuvasive-announces-preliminary-unaudited-full-year-2009-financial-results/</link>
		<comments>http://www.spinejournal.gr/2010/02/nuvasive-announces-preliminary-unaudited-full-year-2009-financial-results/#comments</comments>
		<pubDate>Tue, 02 Feb 2010 08:32:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Alex Lukianov]]></category>
		<category><![CDATA[nuvasive]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=699</guid>
		<description><![CDATA[&#8211;Anticipates Full Year 2009 Revenue of Approximately $370 Million
&#8211;Announces Full Year 2010 Revenue Guidance of $480 Million to $500 Million
SAN DIEGO, Jan 29, 2010 /PRNewswire via COMTEX/ &#8212; NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2010/02/nuvasive-announces-preliminary-unaudited-full-year-2009-financial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NuVasive Reports Third Quarter 2009 Financial Results</title>
		<link>http://www.spinejournal.gr/2009/10/nuvasive-reports-third-quarter-2009-financial-results/</link>
		<comments>http://www.spinejournal.gr/2009/10/nuvasive-reports-third-quarter-2009-financial-results/#comments</comments>
		<pubDate>Fri, 23 Oct 2009 05:25:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Alex Lukianov]]></category>
		<category><![CDATA[nuvasive]]></category>
		<category><![CDATA[XLIF]]></category>

		<guid isPermaLink="false">http://www.spinejournal.gr/?p=578</guid>
		<description><![CDATA[SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ &#8211; NuVasive, Inc. (Nasdaq: NUVA &#8211; News), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended September 30, 2009.
NuVasive reported third quarter revenue of $94.9 million, a 41.8% increase over the $66.9 million for the [...]]]></description>
		<wfw:commentRss>http://www.spinejournal.gr/2009/10/nuvasive-reports-third-quarter-2009-financial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
